DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/c37527/us_diabetes_manage) has announced the addition of the "US Diabetes Management Devices - Market Projections To 2016" report to their offering.
The Market Intelligence report provides critical market data for US diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood glucose monitoring systems and insulin delivery devices. Market Size Market size in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2010 and forecast till 2016.
Market Growth Market growth in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2010 and forecast till 2016. Competitive Analysis Market share (%) of companies is covered at sector and category level for 2010. Pricing Analysis Average selling price ($) for each product type from 2005 - 2010 and forecast till 2016. Cross category comparison and cross sub-category comparison - Forecast and historic market growth and market size comparison for various categories and sub-categories from 2005 to 2010 and 2010 to 2016.
Topics Include:
- Diabetes Management Devices Market Segmentation
- Blood Glucose Monitoring Systems
- Blood Glucose Meters
- Blood Glucose Test Strips
- Continuous Glucose Monitoring Systems
- Continuous Glucose Monitors (CGM)
- CGM Sensors
- Insulin Delivery Devices
- Insulin Pens
- Reusable Insulin Pens
- Disposable Insulin Pens
- Insulin Syringes
- Insulin Pumps
Companies Mentioned:
- Abbott Laboratories
- Animas Corporation
- Apex Biotechnology Corp
- Bayer HealthCare AG
- Becton, Dickinson and Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd
- LifeScan, Inc.
- Medtronic, Inc.
- Novo Nordisk A/S
- Sanofi-Aventis
- Smiths Medical
- Terumo Corporation
For more information visit http://www.researchandmarkets.com/research/c37527/us_diabetes_manage
Source: ABMRG